Related Experiment Videos
The tumor necrosis factors: cachectin and lymphotoxin
1University of Texas Southwestern Medical School, Dallas.
Hospital Practice (Office Ed.)
|February 15, 1990
Summary
Cachectin and lymphotoxin, leukocyte products, cause tissue damage in endotoxemia and tumor necrosis. Understanding these cytokines' inflammatory roles may lead to new disease therapies.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Endotoxemia and tumor necrosis involve significant tissue damage.
- Leukocyte-derived products, cachectin and lymphotoxin, are implicated in these processes.
- These cytokines exhibit potentially systemic toxic effects across organ systems.
Purpose of the Study:
- To elucidate the role of cachectin and lymphotoxin in disease pathogenesis.
- To understand the mechanisms by which these cytokines induce tissue damage.
- To explore therapeutic strategies targeting these inflammatory mediators.
Main Methods:
- Analysis of leukocyte-derived cytokines.
- Investigation of cellular responses to cachectin and lymphotoxin.
- Assessment of organ system effects in models of endotoxemia and tumor necrosis.
Main Results:
- Cachectin and lymphotoxin were identified as key triggers for endotoxemia-induced damage and tumor necrosis.
- These cytokines demonstrated broad toxicity impacting multiple organ systems.
- Evidence suggests a central role in inflammatory pathogenesis.
Conclusions:
- Cachectin and lymphotoxin are critical mediators of inflammatory tissue damage.
- Targeting these cytokines offers potential therapeutic avenues for diverse diseases.
- Further research into cytokine-mediated inflammation is warranted.